Shockwave Medical Inc

US

SWAV

Health Care

328.6 ₽

Current price

Strong sell
328.6 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    362 / 663

  • Position in country

    8442 / 14179

  • Return on Assets, %

    15.1

    -11.9

  • Net income margin, %

    21.8

    -12.5

  • EBITDA margin, %

    22.8

    -2.5

  • Debt to Equity, %

    109.4

    15

  • Intangible assets and goodwill, %

    8.4

    3.9

  • Revenue CAGR 3Y, %

    120.8

    12.6

  • Total Equity change 1Y, %

    30.7

    0

  • Revenue Y, % chg

    49.1

    4.6

  • P/E

    84.9

    28.3

  • P/BV

    18.1

    1.7

  • P/S

    16.8

    3.7

  • EV/S

    16.4

    3.2

  • EV/EBITDA

    71

    -0.2

  • Average Analyst recommendation

    Hold

    Hold

  • Average upside forecasts, %

    2.2

    66.5

  • Forward P/E

    62.9

    19.2

  • Expected dividend per share

    0

    0

  • Payout Ratio, %

    0

    17.3

Get an analytical review of this company

Competitors

Ranks

  • Dexcom Inc

    00%

  • Boston Scientific Corp

    00%

  • Intuitive Surgical Inc

    00%

  • Stryker Corp

    00%

  • Edwards Lifesciences Corp

    00%

  • IDEXX Laboratories Inc

    00%

  • Abbott Laboratories

    00%

  • GE Healthcare Technologies Inc

    00%

  • Shockwave Medical Inc

    00%

  • Becton Dickinson and Co

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    United States of America

  • Sector

    Health Care

  • Industry group

    Health Care Equipment & Services

  • Industry

    Health Care Equipment & Supplies

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    12291.2

  • Ticker

    SWAV.O

  • ISIN

    US82489T1043

  • IPO date

    2019-03-07

  • Availability on Russian exchanges

    Yes

  • Reporting for

    2024-02-26

  • Date fact. publication of reports

    2023-12-31

Company Description

Shockwave Medical, Inc. is a medical device company. The Company is engaged in the development of Intravascular Lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular and heart valve disease. Its products for the treatment of Peripheral Artery disease (PAD) includes Shockwave M5 IVL catheter (M5 catheter) and Shockwave S4 IVL catheter (S4 catheter). Its product for the treatment of Coronary Artery disease (CAD) is Shockwave C2 IVL catheter (C2 catheter). M5 catheter is a five-emitter catheter for use in its IVL System in medium vessels for the treatment of above-the-knee PAD. S4 catheter is a four-emitter catheter for use in its IVL System in small vessels for the treatment of below-the-knee PAD. C2 catheter is a two-emitter catheter for use in its IVL System for the treatment of CAD.

A step towards better analytics

  • find the best promotions through the Screener
  • keep an eye on stock valuation
  • download detailed reports

and much more after free registration

Registration

More convenient from your phone? Download: